Cabozantinib launch date
Cabozantinibis an anti-tumor drug. Cabozantinib is developed by the American biotechnology companyExelixis Inc. was developed and was approved for marketing by the U.S. Food and Drug Administration (FDA) in January 2019. It has not yet been launched in China.

In vitro biochemistry and/or cellular assays show that cabotinib inhibits MET, VEGFR-1, -2 and -3, AXL, RET, < /span>ROS1, TYRO3, MER, KIT, TRKB, FLT-3, and TIE-2. These receptor tyrosine kinases are involved in normal cellular functions and pathological processes, such as tumorigenesis, metastasis, tumor angiogenesis, drug resistance, and maintenance of the tumor microenvironment.
Cabozantinib is used to treat patients with advanced renal cell carcinoma(RCC), as first-line treatment in combination withnivolumab for advanced renal cell carcinoma(RCC) patients, is used in hepatocellular carcinoma(HCC) who have been treated with sorafenib Patients for use in adult and pediatric patients 12 years and older with locally advanced or metastatic differentiated thyroid cancer (DTC) who have progressed after prior VEGFR targeted therapy and are radioactive iodine refractory or ineligible. CabozantinibThe most common(≥ 20%)Adverse reactions include, as a single agent:Diarrhea, fatigue, PPE, decreased appetite, hypertension, nausea, vomiting, weight loss, constipation. In combination with nivolumab: Diarrhea, fatigue, hepatotoxicity, PPE, stomatitis, rash, hypertension, hypothyroidism, musculoskeletal pain, decreased appetite, nausea, dysgeusia, abdominal pain, cough, and upper respiratory tract infection. Laos ASEAN Pharmaceuticals, United Pharmaceuticals, Lucius Pharmaceuticals, Element Pharmaceuticals, etc. are produced, and the cost per box is less than 20mg*90 capsules1,000 yuan. The retail price of Everest Pharmaceuticals, Yaopin International and Beacon Pharmaceuticals in Bangladesh is around 20mg*90 capsules 2000 per box. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)